VANGUARD GROUP INC - ARGOS THERAPEUTICS INC ownership

ARGOS THERAPEUTICS INC's ticker is ARGSXXXX and the CUSIP is 040221103. A total of 26 filers reported holding ARGOS THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of ARGOS THERAPEUTICS INC
ValueSharesWeighting
Q4 2017$157,000
+3.3%
1,045,386
+22.8%
0.00%
Q3 2017$152,000
-46.5%
851,235
+9.1%
0.00%
Q2 2017$284,000
-25.7%
780,035
-7.9%
0.00%
Q1 2017$382,000
-90.0%
847,123
+8.3%
0.00%
Q4 2016$3,834,000
+4.9%
782,336
+6.4%
0.00%
Q3 2016$3,655,000
+58.0%
735,381
+94.8%
0.00%
Q2 2016$2,314,000
+50.6%
377,497
+57.2%
0.00%
Q1 2016$1,537,000
+304.5%
240,107
+45.9%
0.00%
Q4 2015$380,000
-99.8%
164,565
-96.7%
0.00%
-100.0%
Q3 2015$180,983,000
+17574.1%
4,921,822
+3192.5%
0.01%
Q2 2015$1,024,000
-19.7%
149,485
+4.4%
0.00%
Q1 2015$1,276,000
+1.4%
143,205
+13.8%
0.00%
Q4 2014$1,258,000
+0.2%
125,843
+0.8%
0.00%
Q3 2014$1,256,000
+48.3%
124,843
+18.4%
0.00%
Q2 2014$847,000
-24.6%
105,431
-6.2%
0.00%
Q1 2014$1,124,000112,3990.00%
Other shareholders
ARGOS THERAPEUTICS INC shareholders Q3 2015
NameSharesValueWeighting ↓
AWM Investment Company, Inc. 719,305$3,489,0000.68%
WALL STREET ASSOCIATES 257,900$1,243,0000.24%
WASATCH ADVISORS LP 2,298,711$11,149,0000.15%
Pinnacle Summer Investments, Inc. 90,733$507,0000.09%
ALTRINSIC GLOBAL ADVISORS LLC 212,505$1,024,0000.02%
STONERIDGE INVESTMENT PARTNERS LLC 27,024$130,0000.02%
Alyeska Investment Group, L.P. 144,025$694,0000.01%
VANGUARD GROUP INC 4,921,822$180,983,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 40,000$194,0000.00%
CAISSE DE DEPOT ET PLACEMENT DU QUEBEC 317,900$1,542,0000.00%
View complete list of ARGOS THERAPEUTICS INC shareholders